THE OUTCOME OF PANCREATICODUODENECTOMY FOR SOLID PSEUDOPAPILLARY TUMOR AT THE PANCERATIC HEAD IN VIETDUC UNIVERSITY HOSPITAL

Khải Ninh Việt, Công Nguyễn Gia, Đạt Trình Quốc

Main Article Content

Abstract

Objective: To evaluate the early and long-term outcomes of patients after pancreaticoduodenectomy for pseudopapillary solid tumors in the pancreatic head. Methods: A retrospective study of all patients with pancreaticoduodenectomy for pseudopapillary solid tumors at the pancreatic head in Viet Duc Hospital from January 2014 to October 2020. Results: There were 34 patients with pancreaticoduodenectomy for pseudopapillary solid tumors at the pancreatic head in the study, with an average age of 30.9 ± 13.7 years, of which 88.2% were female. Epigastric pain accounted for the highest rate of 70.5%, and asymptomatic patients with incidental disease diagnosis accounted for 29.4%. Computed tomography showed that the tumor had clear boundaries in 90.9%, had a tumor capsule in 75.7%, had tissue and fluid structures in 78.8%, had heterogenous and increasing contrast enhancement in the venous phase in 78.8%, had a dilated common bile duct in 3%, and a dilated Wirsung duct in 6.1%. All patients underwent open surgery to perform the pancreaticoduodenectomy, of which 58.8% had a pancreaticoenteric anastomosis, and 41.2% had a pancreaticogastric anastomosis. The average surgical time was 307 ± 68 minutes, and 64.7% did not require blood transfusion. The average hospital stay was 12.4 ± 3.2 days. The postoperative mortality rate was 0%, postoperative bleeding 2.9%, and 2.9% for pancreatic fistula. The 5-year, 10-year survival rate after surgery was 96.4%, and the 5-year, 10-year recurrence-free rate was 92.8%. 82.1% of patients had good quality of life after surgery. Conclusion: Pancreatoduodenectomy for solid pseudopapillary tumor at pancreatic head was performed safely with low complication rates. Overall survival and disease-free survival rates after 5 and 10 years are high and postoperative quality of life is good.


 

Article Details

References

1. Santini D, Poli F, Lega SJJ. Solid-papillary tumors of the pancreas: histopathology. 2006;7(1):131-136.
2. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. 2020;76(2):182.
3. Fayers PJEOfR, Cancer To. The EORTC QLQ-C30 scoring manual. 2001;
4. Wang P, Wei J, Wu J, et al. Diagnosis and treatment of solid-pseudopapillary tumors of the pancreas: A single institution experience with 97 cases. 2018;18(4):415-419.
5. Antoniou EA, Damaskos C, Garmpis N, et al. Solid pseudopapillary tumor of the pancreas: a single-center experience and review of the literature. 2017;31(4):501-510.
6. Guo T, Wang L, Xie P, Zhang Z, Yu YJCm, research. Diagnosis and surgical treatment and pathological findings of solid pseudopapillary tumor of the pancreas: a single-institution experience. 2020:581-588.
7. Yu P-F, Hu Z-H, Wang X-B, et al. Solid pseudopapillary tumor of the pancreas: a review of 553 cases in Chinese literature. 2010;16(10):1209.
8. Reddy S, Cameron JL, Scudiere J, et al. Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. 2009;208(5):950-957.
9. Okano K, Hirao T, Unno M, et al. Postoperative infectious complications after pancreatic resection. 2015;102(12):1551-1560.